WHO urges increased access to praziquantel as schistosomiasis treatment coverage improves

©I. Prondzynsk
School-aged children queueing up for treatment in Nairobi, Kenya

16 February 2016 | Geneva −− The World Health Organization (WHO) is urging countries to implement WHO recommendations on treating all peoples affected by schistosomiasis (bilharzia), beyond the traditional target of treating only school-age children.

Scaled up interventions have significantly improved global coverage of treatment among school-children and other at-risk groups. In 2014, a global coverage of more than 20% of all people requiring treatment for the disease was achieved.

WHO Collaborating Centre for Malaria, Schistosomiasis and Filariasis in Shanghai renamed as Collaborating Centre for Tropical Diseases

28 October 2015 | Geneva −− The National Institute of Parasitic Diseases (NIPD) of the Chinese Centre for Diseases Control and Prevention in Shanghai, China is a leader in the fight against parasitic diseases, with an influential track record of publishing cutting-edge science about parasite biology, epidemiology, and immunology for more than 60 years.

On 17 October, the NIPD was renamed as the WHO Collaborating Centre for Tropical Diseases which means its research activities will encompass other tropical diseases.

Sudan intensifies its fight against schistosomiasis through large-scale treatment of school-age children

©L. Chitsulo

02 September 2013 | Geneva −− Sudan has launched its 2013 schistosomiasis campaign through large-scale treatment of school-age children in several of its 18 States. A total of six million praziquantel tablets donated by the German pharmaceutical company Merck KGaA through the World Health Organization (WHO) are being delivered.

Schistosomiasis is widely distributed in in Sudan with more than 5 million people, mostly children, requiring treatment.

Schistosomiasis: number of people treated worldwide in 2014
Read more

If you have any queries, please do not hesitate to contact us at